HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

OTC Medical Device Bottleneck Will Have 'Serious Implications' For German Industry, Says BAH’s Dr Cranz

Executive Summary

In an exclusive interview with HBW Insight, the German Medicines Manufacturers´ Association’s (BAH’s) new director general Dr Hubertus Cranz warns of a potentially costly bottleneck forming as German manufacturers scramble to re-certify their self-care medical devices before the May 2020 European Union's new Medical Device Regulations deadline. Dr Cranz also explains how BAH is supporting the country's community pharmacists to help German consumers to self-care safely and responsibly. 
Advertisement

Related Content

Topics

Advertisement
UsernamePublicRestriction

Register

RS149072

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel